The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...
FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.
Monitoring your health stats, from steps to heart rate, can help you get a handle on your fitness goals. But lately, we've seen technology that takes things a step further, enabling at-home tracking ...
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Organizations can stream operational data from enterprise systems into Microsoft Fabric in near real time, helping analytics and AI initiatives move forward without rebuilding pipelines or disrupting ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening its glucose insights push.
I’ve tested my fair share of fitness trackers and wellness products that promise to change your life for the better, but I realized a continuous glucose monitor is different. Instead of making false ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA. The new CGM is designed for patients with Type 2 diabetes who do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results